These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38102564)

  • 1. Subtyping irritable bowel syndrome using cluster analysis: a systematic review.
    Zarei D; Saghazadeh A; Rezaei N
    BMC Bioinformatics; 2023 Dec; 24(1):478. PubMed ID: 38102564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome.
    Guthrie E; Creed F; Fernandes L; Ratcliffe J; Van Der Jagt J; Martin J; Howlett S; Read N; Barlow J; Thompson D; Tomenson B
    Gut; 2003 Nov; 52(11):1616-22. PubMed ID: 14570732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.
    Lackner JM; Jaccard J; Baum C
    Value Health; 2013; 16(1):97-103. PubMed ID: 23337220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
    Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
    Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.
    Black CJ; Ng CE; Goodoory VC; Ford AC
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):386-396.e10. PubMed ID: 36858142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking in Irritable Bowel Syndrome: A Systematic Review.
    Sirri L; Grandi S; Tossani E
    J Dual Diagn; 2017; 13(3):184-200. PubMed ID: 28609199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
    Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
    Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome: A Cluster Analysis.
    Chen J; Zhang Y; Barandouzi ZA; Xu W; Feng B; Chon K; Santos M; Starkweather A; Cong X
    Clin J Pain; 2022 Jul; 38(7):492-501. PubMed ID: 35686579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review.
    Müller A; Franke H; Resch KL; Fryer G
    J Am Osteopath Assoc; 2014 Jun; 114(6):470-9. PubMed ID: 24917634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
    Simrén M; Törnblom H; Palsson OS; Van Oudenhove L; Whitehead WE; Tack J
    Gastroenterology; 2019 Aug; 157(2):391-402.e2. PubMed ID: 31022401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.
    Black CJ; Yiannakou Y; Guthrie E; West R; Houghton LA; Ford AC
    Aliment Pharmacol Ther; 2021 May; 53(10):1126-1137. PubMed ID: 33705578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.
    Windgassen S; Moss-Morris R; Chilcot J; Sibelli A; Goldsmith K; Chalder T
    Br J Health Psychol; 2017 Nov; 22(4):701-736. PubMed ID: 28573818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
    McKenzie YA; Thompson J; Gulia P; Lomer MC;
    J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.